BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 89620)

  • 21. [Vaccination against viral diseases].
    Stickl VH
    Fortschr Med; 1976 Feb; 94(4):159-64. PubMed ID: 56296
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hepatitis viruses of man: transmission, epidemiology and immunology (author's transl)].
    Laufs R; Salefsky C
    Monatsschr Kinderheilkd; 1980 Aug; 128(8):511-7. PubMed ID: 6107830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of measles virus-specific cytotoxic antibodies by use of a chronically infected cell line.
    Ehrnst AC
    J Immunol; 1975 Mar; 114(3):1077-82. PubMed ID: 1089724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioimmunoassay in diagnostic virology.
    Halonen P; Meurman O
    Lab Res Methods Biol Med; 1982; 5():83-124. PubMed ID: 6281600
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum and CSF antibody levels to herpes simplex type 1, measles and rubella viruses in patients with schizophrenia.
    Rimón R; Nishmi M; Halonen P
    Ann Clin Res; 1978 Oct; 10(5):291-3. PubMed ID: 216300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation on the role of viral antibodies in the pathogenesis of multiple sclerosis.
    Matveeva TV; Pille ER; Diakonova IN; Andreeva AP
    Acta Virol; 1980 Dec; 24(6):415-20. PubMed ID: 6111202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hepatitis A: antibody conversion under gamma globulin (author's transl)].
    Ambrosch F; Kunz C; Frisch-Niggemeyer W; Wiedermann G; Wustinger E
    Wien Klin Wochenschr; 1980 Feb; 92(5):156-7. PubMed ID: 6156546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Solid-phase enzyme immunoassay for specific immunoglobulin G and immunoglobulin M antibodies of rubella virus (author's transl)].
    Prévot J; Guesdon JL
    Ann Microbiol (Paris); 1977; 128B(4):531-40. PubMed ID: 610503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia.
    Nokes DJ; Enquselassie F; Nigatu W; Vyse AJ; Cohen BJ; Brown DW; Cutts FT
    Bull World Health Organ; 2001; 79(7):588-95. PubMed ID: 11477961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Standardization of the antibody to hepatitis A virus (anti-HAV) content of immunoglobulin.
    Gerety RJ; Smallwood LA; Finlayson JS; Tabor E
    Dev Biol Stand; 1983; 54():411-6. PubMed ID: 6317492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Studies on human immunoglobulin preparations: II. Purity and composition (author's transl)].
    Scheiermann N; Kuwert EK
    Med Klin; 1979 May; 74(21):825-9. PubMed ID: 89621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Is the rheumatoid arthritis of children a late complication of rubella? (proceedings)].
    Petersen EE; Burger A; Stoeber E
    Z Rheumatol; 1976; 35 Suppl 4():suppl 21-5. PubMed ID: 185840
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prophylactic effectiveness of immunoglobulin preparations with different amounts of specific antibodies to the hepatitis A virus].
    Perepelkin VS; Sumarokov AA; Gorbunov MA; Tiantov GA; Borzykh VA
    Voen Med Zh; 1988 Dec; (12):37-9. PubMed ID: 2853893
    [No Abstract]   [Full Text] [Related]  

  • 34. [The elimination of nonspecific reaction in ELISA --for the application of routine serological test on varicella zoster, measles and rubella virus (author's transl)].
    Mizutani C; Hirayama M; Minamitani M
    Kansenshogaku Zasshi; 1981 Mar; 55(3):143-8. PubMed ID: 6268717
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antibodies to rubella virus in the blood sera and in the synovial fluid of children with rheumatoid arthritis].
    Lozovskaia LS; Desiatskova RG; Mitchenko AF; Pokryshkina EL; Shigina OM
    Vopr Virusol; 1980; (4):468-73. PubMed ID: 6252699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The therapy with immunoglobulins. Structure, mechanisms of action and the intravenous use of gammaglobulin preparations (author's transl)].
    Schulte-Wissermann H; Schofer O; Dinkel E
    Immun Infekt; 1982 May; 10(3):98-109. PubMed ID: 6178676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hemagglutination-inhibiting antibodies to virus antigens in placental gamma-globulin].
    Opochinskiĭ EF; Desiatskova RG; Andzhaparidze OG
    Zh Mikrobiol Epidemiol Immunobiol; 1972 May; 49(5):60-4. PubMed ID: 4114017
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effectiveness of intravenous gammaglobulin preparations: comparison between Sandoglobulin and gamma-Venin in the prevention of rubella infections].
    Petersen EE
    Dtsch Med Wochenschr; 1982 Dec; 107(49):1878-81. PubMed ID: 6183089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterisation of various intravenous immunoglobulin preparations.
    Lundblad JL; Londeree N; Mitra G
    J Infect; 1987 Jul; 15 Suppl 1():3-12. PubMed ID: 2822815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Idiopathic cardiomyopathy. A study on the infectious-immune theory as a cause of the disease.
    Kawai C
    Jpn Circ J; 1971 Jul; 35(7):765-70. PubMed ID: 4329901
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.